September 15, 2022
“What if…?” The Fear of an Increased Risk of Cancer Is Not Compensable Damage Justifying a Class Action
On August 12, 2022, in Palmer v. Teva Canada Ltd., 2022 ONSC 4690, the Ontario Superior Court of Justice dismissed an application for authorization to bring a class action against the manufacturers of a hypertension drug sold under the generic name of valsartan. The application was filed in 2018, a few days after the manufacturers […]